Endometrial cancer and precancerous lesions
Conditions
Interventions
Gold Standard:Pathological examination results after hysteroscopic curettage
Index test:Serum HE4 value
Sponsors
People's Hospital of Shapingba District, Chongqing
Eligibility
Sex/Gender
Female
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged >=35 years, with a history of abnormal uterine bleeding and confirmed by hysteroscopic biopsy as normal proliferative endometrium, benign endometrial hyperplasia, endometrial hyperplasia with atypical and endometrial cancer.
Exclusion criteria
Exclusion criteria: 1. Patients with other endometrial lesions (such as endometrial polyps, submucosal fibroids, etc.); 2. Patients with liver and kidney disease, adnexal disease, uterine fibroids >5cm, other malignant tumors, and a history of radiotherapy and chemotherapy; 3. Unable to perform hysteroscopy to biopsy; 4. Those who refused to participate in this clinical trial or refused to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Human epididymal protein; | — |
Countries
China
Contacts
Public ContactLi Ning
People's Hospital of Shapingba District, Chongqing
Outcome results
None listed